Fate: Acquired by Acorda, Sept 2014, $525M. Formerly an Alkermes spinout.
If you believe any of this information is incorrect, please
let us know
terms and conditions
BioPharmGuy is a registered trademark of Wilsonian LLC, Website content © 2019 Wilsonian LLC